Join to view full profile
635 W 165th StSuite 214New York, NY 10032
Phone+1 212-342-3401
Fax+1 212-305-5962
Dr. Coleman is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Hanna Coleman, MD is an Ophthalmologist based in New York, NY, with a subspecialty in retinal disease, particularly vitreoretinal disease. She received her MD from Weill Cornell Medicine in 1996, subsequently completing an internship in Internal Medicine at Zucker School of Medicine at Hofstra/Northwell, and a residency in Ophthalmology at New York Presbyterian Hospital. Dr. Coleman has had several publications on retinal disease presented in esteemed journals such as the Journal of Ultrasound in Medicine and the American Journal of Ophthalmology, each cited multiple times by other publications.
Education & Training
New York Presbyterian Hospital (Cornell Campus)Residency, Ophthalmology, 1997 - 2000
Zucker School of Medicine at Hofstra/NorthwellInternship, Internal Medicine, 1996 - 1997
Weill Cornell MedicineClass of 1996
Certifications & Licensure
NY State Medical License 1997 - 2027
MD State Medical License 2003 - 2008
American Board of Ophthalmology Ophthalmology
Publications & Presentations
PubMed
- Visionary AI: Decoding Systemic Vascular Health and Hypertensive Disorders in Pregnancy Through Retinal Imaging and Artificial Intelligence.Srilaxmi Bearelly, Cassandra Areff, Matthew K Hoffman, Daniel Sunko, Andrew F Laine
Medrxiv. 2025-11-27 - Corrigendum.Henry E Wiley, Ramaprasad Srinivasan, Jodi K Maranchie, Jay Chhablani, Ane Bundsbæk Bøndergaard Iversen
Ophthalmology. 2025-03-01 - 7 citationsOral Hypoxia-Inducible Factor 2α Inhibitor Belzutifan in Ocular von Hippel-Lindau Disease: Subgroup Analysis of the Single-Arm Phase 2 LITESPARK-004 Study.Henry E Wiley, Ramaprasad Srinivasan, Jodi K Maranchie, Jay Chhablani, Ane Bundsbæk Bøndergaard Iversen
Ophthalmology. 2024-11-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
